{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:37Z","timestamp":1787026477190,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Chronic low-grade inflammation is involved in the pathogenesis of type-1 diabetes (T1D) and its complications. In this cross-section study design, we investigated association between serum levels of soluble cytokine receptors with presence of peripheral neuropathy in 694 type-1 diabetes patients. Sex, age, blood pressure, smoking, alcohol intake, HbA1c and lipid profile, presence of DPN (peripheral and autonomic), retinopathy and nephropathy was obtained from patient\u2019s chart. Measurement of soluble cytokine receptors, markers of systemic and vascular inflammation was done using multiplex immunoassays. Serum levels were elevated in in DPN patients, independent of gender, age and duration of diabetes. Crude odds ratios were significantly associated with presence of DPN for 15\/22 proteins. The Odds ratio (OR) remained unchanged for sTNFRI (1.72, p=0.00001), sTNFRII (1.45, p=0.0027), sIL2R\u03b1 (1.40, p=0.0023), IGFBP6 (1.51, p=0.0032) and CRP (1.47, p=0.0046) after adjusting for confounding variables, HbA1C, hypertension and dyslipidemia. Further we showed risk of DPN is associated with increase in serum levels of sTNFRI (OR=11.2, p&amp;lt;10), sIL2R\u03b1 (8.69, p&amp;lt;10\n                    <jats:sup>-15<\/jats:sup>\n                    ), sNTFRII (4.8, p&amp;lt;10\n                    <jats:sup>-8<\/jats:sup>\n                    ) and MMP2 (4.5, p&amp;lt;10\n                    <jats:sup>-5<\/jats:sup>\n                    ). We combined the serum concentration using ridge regression, into a composite score, which can stratify the DPN patients into low, medium and high-risk groups. Our results here show activation of inflammatory pathway in DPN patients, and could be a potential clinical tool to identify T1D patients for therapeutic intervention of anti-inflammatory therapies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.654233","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T02:00:21Z","timestamp":1617156021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes Cohort"],"prefix":"10.3389","volume":"12","author":[{"given":"Sharad","family":"Purohit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Minh Huy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn Kim Hoang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Bin","family":"Satter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramohan","family":"Wakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Chip","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xiong","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldp053","article-title":"Prevention and treatment of microvascular disease in childhood type 1 diabetes","volume":"94","author":"Marcovecchio","year":"2010","journal-title":"Br Med Bull"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2165\/11585220-000000000-00000","article-title":"Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus","volume":"70","author":"Mattila","year":"2010","journal-title":"Drugs"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2010.05.009","article-title":"Complications of type 1 diabetes","volume":"39","author":"Melendez-Ramirez","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic Somatic Neuropathies","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.6.1480","article-title":"Underdiagnosis of peripheral neuropathy in type 2 diabetes","volume":"28","author":"Herman","year":"2005","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0744","article-title":"Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study","volume":"36","author":"Bongaerts","year":"2013","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0076","article-title":"Rethinking Neuropathy in Type 1 Diabetes: Had We Lost Sight of What Matters Most","volume":"43","author":"Perkins","year":"2020","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1582","article-title":"Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland","volume":"43","author":"Jeyam","year":"2020","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2337\/dc19-1583","article-title":"The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange","volume":"43","author":"Mizokami-Stout","year":"2020","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050586","article-title":"Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic Neuropathy: A Position Statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/bs.irn.2016.02.020","article-title":"Neuropathy in the DCCT\/EDIC-What Was Done Then and What We Would Do Better Now","volume":"127","author":"Pop-Busui","year":"2016","journal-title":"Int Rev Neurobiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0249","article-title":"Prevalence of Diabetic Neuropathy in Young Adults with Type 1 Diabetes and the Association with Insulin Pump Therapy","volume":"20","author":"Christensen","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2337\/diabetes.38.11.1456","article-title":"Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study","volume":"38","author":"Maser","year":"1989","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0179","article-title":"Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study","volume":"40","author":"Jaiswal","year":"2017","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","article-title":"Inflammation as a Therapeutic Target for Diabetic Neuropathies","volume":"16","author":"Pop-Busui","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12794","article-title":"Role of inflammatory biomarkers in diabetic peripheral neuropathy","volume":"9","author":"Jin","year":"2018","journal-title":"J Diabetes Investig"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2534","article-title":"Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications","volume":"94","author":"Goldberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7786","article-title":"Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes","volume":"86","author":"Zoppini","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00154","article-title":"Proteins of TNF-\u03b1 and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria","volume":"9","author":"Purohit","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"279393","DOI":"10.1155\/2015\/279393","article-title":"Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes","volume":"2015","author":"Sharma","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1628-8","article-title":"Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes\u2013the EURODIAB Prospective Complications Study","volume":"48","author":"Schram","year":"2005","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02376.x","article-title":"Diabetic neuropathy is associated with activation of the TNF-\u03b1 system in subjects with type 1 diabetes mellitus","volume":"63","author":"Gonz\u00e1lez-Clemente","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00002","article-title":"IGF-Binding Proteins in Type-1 Diabetes Are More Severely Altered in the Presence of Complications","volume":"7","author":"Sharma","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-1388","article-title":"Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1\u03b2 in Patients With Type 1 Diabetes","volume":"100","author":"Purohit","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"M111.012203","DOI":"10.1074\/mcp.M111.012203","article-title":"Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays","volume":"10","author":"Zhi","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors","volume":"175","author":"Aderka","year":"1992","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00343","article-title":"T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update","volume":"8","author":"Su","year":"2017","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12964-019-0356-0","article-title":"Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor \u03b1 to gp130 expression: fusing experimental insights and dynamic modelling","volume":"17","author":"Reeh","year":"2019","journal-title":"Cell Commun Signaling"},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1155\/EDR.2003.65","article-title":"The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy","volume":"4","author":"Satoh","year":"2003","journal-title":"Exp Diabesity Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12913","article-title":"Associations between circulating inflammatory markers, diabetes type and complications in youth","volume":"20","author":"Aulich","year":"2019","journal-title":"Pediatr Diabetes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.654233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T02:00:24Z","timestamp":1617156024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.654233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2021.654233"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.654233","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"article-number":"654233"}}